For decades, scientists have assumed that recursion, the capacity to nest meaningful structures in other structures, like a set of Russian dolls, was a characteristic specific to humans. This ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best AI stocks to buy according to hedge funds. Earlier on June 6, ...

With a technique called cell painting, Recursion Pharmaceuticals is creating a really big picture of morphology of cells in the body. But that's just the beginning; the really hard part is knowing ...

Dr. James McCaffrey from Microsoft Research presents a complete end-to-end demonstration of decision tree regression using the C# language. Unlike most implementations, this one does not use recursion ...

Recursion, whose advisers include AI pioneer Yoshua Bengio, will use its biological and chemical datasets exceeding 23,000 terabytes to train AI models on Nvidia's cloud platform.

Recursion CEO Chris Gibson, PhD, predicts AI will cut drug discovery costs and discusses his company's collaboration with Nvidia.

Recursion Pharmaceuticals has a prescription for high drug costs: AI and 25 petabytes of data Growing interest in AI-powered drug discovery draws some big investors–and regulatory questions ...

Named RxRx19, the dataset from Recursion is an important contribution to a growing body of scientific data in the fight against COVID-19.